We are live on ! Find out more
ESPR

Esperion Therapeutics

Delisted

ESPR was delisted on the 10th of July, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
PCM
1
Pentwater Capital Management
Florida
$92M +$5.58M +151,800 +8%
BB
2
BB Biotech
Switzerland
$70M +$3.86M +105,000 +7%
State Street
3
State Street
Massachusetts
$69.7M +$40.2M +1,093,292 +265%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$62M +$1.1M +30,000 +2%
BlackRock
5
BlackRock
New York
$59.2M -$137K -3,738 -0.3%
CS
6
Credit Suisse
Switzerland
$51.5M +$8.64M +234,971 +27%
BC
7
Boxer Capital
California
$46.3M -$10.1M -275,000 -22%
DCM
8
Discovery Capital Management
Connecticut
$44.7M +$21.5M +583,529 +153%
AC
9
Aisling Capital
New York
$38.7M
Vanguard Group
10
Vanguard Group
Pennsylvania
$35M +$1.18M +32,074 +4%
WA
11
Wasatch Advisors
Utah
$35M -$398K -10,828 -1%
PA
12
Pinnacle Associates
New York
$34M -$1.33M -36,165 -5%
RCM
13
RA Capital Management
Massachusetts
$33.9M +$987K +26,830 +4%
MG
14
Meditor Group
Bermuda
$26.2M +$20.8M +566,000 New
Northern Trust
15
Northern Trust
Illinois
$20.1M -$3.26M -88,697 -17%
RPAM
16
Rhenman & Partners Asset Management
Sweden
$16.8M -$6.62M -180,000 -33%
AH
17
Aviva Holdings
Bahamas
$15.7M
PCM
18
Peregrine Capital Management
Minnesota
$14.7M +$11.7M +318,667 New
Invesco
19
Invesco
Georgia
$13.6M +$10.5M +284,897 +3,552%
Goldman Sachs
20
Goldman Sachs
New York
$11.6M +$6.9M +187,728 +303%
GH
21
GAM Holding
Switzerland
$10.4M
PHS
22
PFM Health Sciences
California
$9.9M +$7.87M +213,980 New
PC
23
Paulson & Co
New York
$9.74M -$783K -21,300 -9%
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$9.28M +$5.55M +150,983 +305%
PAMU
25
Pictet Asset Management (UK)
United Kingdom
$8.74M +$5.31M +144,339 +112%